COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

Peripheral Artery Disease- New Data and New Guidelines. Medical Ther…

Top Ten Topics in Clinical Cardiology 2024

M. Bonaca

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Management of AF patients with ACS

Lankenau

P. Kowey, D. Ice

VTE Prophylaxis After THA for Asian Population: Pharmacological Prop…

Arthroplasty Society in Asia

M. Mihara

AHA 2024 Insights: Considerations in Care of Patients with Cancer: P…

AHA 2024 Insights

Y. Bryce

VTE Prophylaxis After THA: Chinese Experience

Arthroplasty Society in Asia

H. Cai

Medical Management of Peripheral Arterial Disease

NY Endovascular Summit

H. Kamran

DAPT Following ACS: Does One Size Fit All?

Canadian Collaborative Research Network

M. Bonaca

VTE Prophylaxis After THA in the Asians: Messages from 2019 AP VTE C…

Arthroplasty Society in Asia

A. Tanavalee

Time to Retire Aspirin?

Top Ten Topics in Clinical Cardiology 2021

R. Mehran

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Piedmont Heart Institute

A. Klein

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

BMFcases

T. Bat, M. Carrier

Atrial Fibrillation Management: How Do We Implement “Risk Factor Mod…

ARCH Advanced Revascularization Symposium

J. Mandrola

Acute DVT: When to and When Not to Intervene?

Venous Edge

S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

Risk Factors and Medical Management of PAD

Jefferson Health

T. Galanis

Prevention and Treatment of Cancer-Associated Thrombosis: What Are t…

James Douketis

Cancer-Associated Thrombosis: Anticoagulant Dose and Duration Consid…

BMFcases

T. Bat, M. Carrier